These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20071289)

  • 1. Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections.
    Mirone V; Fusco F; Taglialatela D; Verze P; Di Vito C; Lotti T; Imbimbo C;
    J Chemother; 2009 Dec; 21(6):651-60. PubMed ID: 20071289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
    Talan DA; Naber KG; Palou J; Elkharrat D
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women.
    Fourcroy JL; Berner B; Chiang YK; Cramer M; Rowe L; Shore N
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4137-43. PubMed ID: 16189090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option.
    Blondeau JM
    Drugs; 2004; 64(6):611-28. PubMed ID: 15018591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
    Naber KG; Allin DM; Clarysse L; Haworth DA; James IG; Raini C; Schneider H; Wall A; Weitz P; Hopkins G; Ankel-Fuchs D
    Int J Antimicrob Agents; 2004 Jun; 23(6):596-605. PubMed ID: 15194131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis.
    Talan DA; Klimberg IW; Nicolle LE; Song J; Kowalsky SF; Church DA
    J Urol; 2004 Feb; 171(2 Pt 1):734-9. PubMed ID: 14713799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin extended release: in the treatment of urinary tract infections and uncomplicated pyelonephritis.
    Waugh J; Keating GM
    Drugs Aging; 2004; 21(1):55-64; discussion 65-6. PubMed ID: 14715044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complicated urinary tract infections treated with extended-release ciprofloxacin with emphasis on Pseudomonas aeruginosa.
    Saltzstein D; Wachs B; Perroncel R; Benson A; Herrington J; Haverstock D; Pertel P
    J Chemother; 2007 Dec; 19(6):694-702. PubMed ID: 18230553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study.
    Pisani E; Bartoletti R; Trinchieri A; Rizzo M
    J Chemother; 1996 Jun; 8(3):210-3. PubMed ID: 8808718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of nevirapine extended-release once daily versus nevirapine immediate-release twice-daily in treatment-naive HIV-1-infected patients.
    Gathe J; Andrade-Villanueva J; Santiago S; Horban A; Nelson M; Cahn P; Bogner J; Spencer D; Podzamczer D; Yong CL; Nguyen T; Zhang W; Drulak M; Quinson AM
    Antivir Ther; 2011; 16(5):759-69. PubMed ID: 21817198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
    Peterson J; Kaul S; Khashab M; Fisher AC; Kahn JB
    Urology; 2008 Jan; 71(1):17-22. PubMed ID: 18242357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complicated urinary infection in spinal injury patients: fleroxacin compared with ciprofloxacin.
    Whitby M; Angus L; Nimmo G; Hill V
    Chemotherapy; 1996; 42(6):468-72. PubMed ID: 8957583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
    Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.
    Gomolin IH; Siami PF; Reuning-Scherer J; Haverstock DC; Heyd A;
    J Am Geriatr Soc; 2001 Dec; 49(12):1606-13. PubMed ID: 11843992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections.
    Naber KG; Bartnicki A; Bischoff W; Hanus M; Milutinovic S; van Belle F; Schönwald S; Weitz P; Ankel-Fuchs D
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S41-53. PubMed ID: 15037328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial.
    Vogel T; Verreault R; Gourdeau M; Morin M; Grenier-Gosselin L; Rochette L
    CMAJ; 2004 Feb; 170(4):469-73. PubMed ID: 14970093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections.
    Carmignani G; De Rose AF; Olivieri L; Salvatori E; Rosignoli MT; Dionisio P
    Urol Int; 2005; 74(4):326-31. PubMed ID: 15897698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women.
    Raz R; Naber KG; Raizenberg C; Rohana Y; Unamba-Oparah I; Korfman G; Yaniv I
    Eur J Clin Microbiol Infect Dis; 2000 May; 19(5):327-31. PubMed ID: 10898131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.